Other molecules studied in this regard include the kidney injury molecule-1 (KIM-1), the liver-type fatty acid-binding protein (L-FABP), and interleukin-18 (IL-18); however, evidence from multiple clinical studies shows a variable potential to predict the initiation and/or progression of kidney injury [20,21]. Here, FABP1 is linked to kidney injury.